AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 280: F823-F828, 2001;
0363-6127/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaziri, N. D.
Right arrow Articles by Parks, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaziri, N. D.
Right arrow Articles by Parks, J. S.
Vol. 280, Issue 5, F823-F828, May 2001

Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome

N. D. Vaziri1, K. Liang1, and J. S. Parks2

1 Division of Nephrology, Department of Medicine, University of California, Irvine, Irvine, California 92697; and 2 Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157

Lecithin-cholesterol acetyltransferase (LCAT) is involved in the synthesis of plasma cholesteryl esters and is pivotal in the maturation of plasma high-density lipoprotein (HDL) and conversion of HDL3 to HDL2. In nephrotic syndrome (NS), the ratio of HDL2 to HDL3 is low even though the total concentration of HDL is generally normal. We hypothesize that the reduced HDL2/HDL3 ratio in NS is due to urinary losses of LCAT, leading to plasma LCAT deficiency. To test this hypothesis, Sprague-Dawley rats were randomized to NS (given 130 mg puromycin aminonucleoside on day 1 and 60 mg ip on day 14) or control groups and were studied on day 30. To dissect the effect of proteinuria from hypoalbuminemia, a group of Nagase rats with inherited hypoalbuminemia was included. Hepatic LCAT and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA abundance and plasma and urine LCAT activity were measured. The NS group showed a fourfold rise in serum cholesterol and triglycerides, a fivefold rise in free cholesterol, and a fourfold fall in the HDL-to-total cholesterol ratio. Despite severe hypoalbuminemia, the Nagase rats showed only a mild elevation of serum cholesterol and triglycerides with a normal serum free cholesterol and HDL-to-total cholesterol ratio. The NS group exhibited a normal hepatic LCAT-to-GAPDH mRNA ratio, a marked reduction in plasma LCAT activity, and a significant increase in urinary LCAT excretion. LCAT/GAPDH mRNA and plasma and urine LCAT were normal in Nagase rats. Thus NS led to heavy urinary losses and reduced plasma concentration of LCAT, despite normal hepatic LCAT mRNA abundance. However, hypoalbuminemia, per se, without proteinuria as seen in the Nagase rats had no effect on plasma LCAT or the HDL-to-total cholesterol ratio. Therefore, proteinuria, not hypoalbuminemia, causes LCAT deficiency and a depressed HDL-to-total cholesterol ratio in NS.

proteinuria; hyperlipidemia; hypercholesterolemia; hypoalbuminemia; hypertriglyceridemia; arteriosclerosis; high- density lipoprotein


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
N. D. Vaziri
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F262 - F272.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. C. Shearer, J. W. Newman, B. D. Hammock, and G. A. Kaysen
Graded Effects of Proteinuria on HDL Structure in Nephrotic Rats
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1309 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Kim, C. H. Kim, and N. D. Vaziri
Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E813 - E817.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
W. A Prescott Jr, D.-a. D Streetman, and D. S Streetman
The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome
Ann. Pharmacother., December 1, 2004; 38(12): 2105 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. D. Vaziri, C. H. Kim, B. Dang, C.-D. Zhan, and K. Liang
Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure
Am J Physiol Renal Physiol, July 1, 2004; 287(1): F90 - F94.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Liang and N. D. Vaziri
Upregulation of acyl-CoA:cholesterol acyltransferase in chronic renal failure
Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E676 - E681.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online